Bausch Health Companies Inc. NYSE:BHC

Bausch Health Companies stock price today

$7.839
+0.18
+2.47%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bausch Health Companies stock price monthly change

+3.10%
month

Bausch Health Companies stock price quarterly change

+3.10%
quarter

Bausch Health Companies stock price yearly change

-1.29%
year

Bausch Health Companies key metrics

Market Cap
2.74B
Enterprise value
22.96B
P/E
-12.1
EV/Sales
2.82
EV/EBITDA
8.45
Price/Sales
0.34
Price/Book
-3.99
PEG ratio
-0.15
EPS
-0.04
Revenue
8.95B
EBITDA
-1.07B
Income
-20.71M
Revenue Q/Q
10.25%
Revenue Y/Y
9.89%
Profit margin
-2.77%
Oper. margin
17.12%
Gross margin
70.9%
EBIT margin
17.12%
EBITDA margin
-12.04%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bausch Health Companies stock price history

Bausch Health Companies stock forecast

Bausch Health Companies financial statements

Average Price Target
Last Year

$10

Potential upside: 27.56%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Bausch Health Companies Inc. (NYSE:BHC): Profit margin
Jun 2023 2.16B 26M 1.2%
Sep 2023 2.23B -378M -16.89%
Dec 2023 2.40B 395M 16.4%
Mar 2024 2.14B -63.71M -2.97%
Bausch Health Companies Inc. (NYSE:BHC): Debt to assets
Jun 2023 33796830630 33.43B 98.94%
Sep 2023 27064000000 27.29B 100.87%
Dec 2023 27350000000 27.43B 100.3%
Mar 2024 26885256733 27.05B 100.65%
Bausch Health Companies Inc. (NYSE:BHC): Cash Flow
Jun 2023 268.77M -37.61M -120M
Sep 2023 282M -1.88B 1.81B
Dec 2023 390M -148M -79M
Mar 2024 206.07M -72.67M -334.49M

Bausch Health Companies alternative data

Bausch Health Companies Inc. (NYSE:BHC): Employee count
Sep 2023 19,900
Oct 2023 19,900
Nov 2023 19,900
Dec 2023 19,900
Jan 2024 19,900
Feb 2024 19,900
Apr 2024 20,270
May 2024 20,270
Jun 2024 20,270
Jul 2024 20,270

Bausch Health Companies other data

60.55% -5.19%
of BHC is owned by hedge funds
219.29M -17.88M
shares is hold by hedge funds

Bausch Health Companies Inc. (NYSE:BHC): Insider trades (number of shares)
Period Buy Sel
Mar 2024 0 6313
Sep 2024 0 13370
Dec 2024 0 440
Transaction Date Insider Security Shares Price per share Total value Source
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 440 $8.35 $3,674
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 13,370 $6.21 $83,028
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 4,420 $9.8 $43,316
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 199 $9.8 $1,950
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 1,561 $9.8 $15,298
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 133 $9.8 $1,303
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 220 $7.38 $1,624
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 43 $7.61 $327
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 6,685 $8.28 $55,352
Sale
CARSON SEANA officer: EVP, General Counsel
Common Shares, No Par Value 495 $9.17 $4,539
Thursday, 12 December 2024
reuters.com
accesswire.com
Wednesday, 11 December 2024
benzinga.com
Friday, 6 December 2024
seekingalpha.com
Thursday, 5 December 2024
accesswire.com
Monday, 2 December 2024
seekingalpha.com
Friday, 29 November 2024
zacks.com
Monday, 25 November 2024
zacks.com
Monday, 18 November 2024
reuters.com
accesswire.com
Thursday, 14 November 2024
businesswire.com
Wednesday, 6 November 2024
zacks.com
Monday, 4 November 2024
zacks.com
Friday, 1 November 2024
zacks.com
Wednesday, 30 October 2024
zacks.com
zacks.com
seekingalpha.com
businesswire.com
Sunday, 27 October 2024
accesswire.com
Wednesday, 23 October 2024
zacks.com
Monday, 14 October 2024
benzinga.com
businesswire.com
Wednesday, 9 October 2024
accesswire.com
Tuesday, 8 October 2024
accesswire.com
Wednesday, 25 September 2024
marketbeat.com
Monday, 23 September 2024
zacks.com
Sunday, 22 September 2024
investorplace.com
Thursday, 19 September 2024
seekingalpha.com
zacks.com
seekingalpha.com
  • What's the price of Bausch Health Companies stock today?

    One share of Bausch Health Companies stock can currently be purchased for approximately $7.84.

  • When is Bausch Health Companies's next earnings date?

    Unfortunately, Bausch Health Companies's (BHC) next earnings date is currently unknown.

  • Does Bausch Health Companies pay dividends?

    No, Bausch Health Companies does not pay dividends.

  • How much money does Bausch Health Companies make?

    Bausch Health Companies has a market capitalization of 2.74B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.79% to 8.76B US dollars.

  • What is Bausch Health Companies's stock symbol?

    Bausch Health Companies Inc. is traded on the NYSE under the ticker symbol "BHC".

  • What is Bausch Health Companies's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Bausch Health Companies?

    Shares of Bausch Health Companies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Bausch Health Companies's key executives?

    Bausch Health Companies's management team includes the following people:

    • Mr. Joseph C. Papa Chief Executive Officer & Chairman(age: 69, pay: $3,740,000)
    • Mr. Thomas J. Appio Pres & Co-Head Bausch + Lomb/International(age: 63, pay: $2,160,000)
    • Mr. Paul S. Herendeen Executive Vice President and Advisor to Chairman & Chief Executive Officer(age: 69, pay: $2,100,000)
    • Ms. Christina M. Ackermann Executive Vice President, Gen. Counsel & Head of Commercial Operations(age: 60, pay: $1,310,000)
  • How many employees does Bausch Health Companies have?

    As Jul 2024, Bausch Health Companies employs 20,270 workers.

  • When Bausch Health Companies went public?

    Bausch Health Companies Inc. is publicly traded company for more then 31 years since IPO on 29 Mar 1994.

  • What is Bausch Health Companies's official website?

    The official website for Bausch Health Companies is bauschhealth.com.

  • Where are Bausch Health Companies's headquarters?

    Bausch Health Companies is headquartered at 2150 St. ElzEar Boulevard West, Laval, QC.

  • How can i contact Bausch Health Companies?

    Bausch Health Companies's mailing address is 2150 St. ElzEar Boulevard West, Laval, QC and company can be reached via phone at +1 514 744 6792.

  • What is Bausch Health Companies stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for Bausch Health Companies in the last 12 months, the avarage price target is $10. The average price target represents a 27.56% change from the last price of $7.84.

Bausch Health Companies company profile:

Bausch Health Companies Inc.

bauschhealth.com
Exchange:

NYSE

Full time employees:

20,270

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8

CIK: 0000885590
ISIN: CA0717341071
CUSIP: 071734107